UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

Neuro-oncology (Charlottesville, Va.), 2015-09, Vol.17 (9), p.1188-1198

2015

Volltextzugriff (PDF)

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

Oncogene, 2004-03, Vol.23 (10), p.1821-1828

2004

Volltextzugriff (PDF)

Role of AKT signaling in DNA repair and clinical response to cancer therapy

Neuro-oncology (Charlottesville, Va.), 2014-10, Vol.16 (10), p.1313-1323

2014

Volltextzugriff (PDF)

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity

Oncogene, 2002-04, Vol.21 (15), p.2357-2364

2002

Volltextzugriff (PDF)

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE

Clinical cancer research, 2018-02, Vol.24 (4), p.737-743

2018

Volltextzugriff (PDF)

Current clinical development of PI3K pathway inhibitors in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-07, Vol.14 (7), p.819-829

2012

Volltextzugriff (PDF)

Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells

Oncogene, 2001-06, Vol.20 (28), p.3665-3673

2001

Volltextzugriff (PDF)

Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center

European journal of cancer (1990), 2019-05, Vol.112, p.83-93

2019

Volltextzugriff (PDF)

Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro

Oncogene, 1997-10, Vol.15 (17), p.2049-2057

1997

Volltextzugriff (PDF)

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02

Journal of neuro-oncology, 2018-01, Vol.136 (1), p.79-86

2018

Volltextzugriff (PDF)

Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma

Oncogene, 1997-01, Vol.14 (3), p.369-373

1997

Volltextzugriff (PDF)

Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway

Journal of neuro-oncology, 2012-05, Vol.107 (3), p.487-501

2012

Volltextzugriff (PDF)

Abstract CT238: Phase 2 study of dianhydrogalactitol (VAL-083) inpatients with MGMT-unmethylated, bevacizumab-naivepatients with MGMT-unmethylated, bevacizumab-naïve glioblastoma in the recurrent and adjuvant setting

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT238-CT238

2021

Volltextzugriff (PDF)

Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients

Cancer chemotherapy and pharmacology, 2012-06, Vol.69 (6), p.1507-1518

2012

Volltextzugriff (PDF)

Abstract 2798: Identification of gamma secretase inhibitor (GSI)-responsive GBM patients: Involvement of NOTCH, p53, and PI3K/MAPK signaling

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2798-2798

2017

Volltextzugriff (PDF)

Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs

American journal of cancer research, 2019-01, Vol.9 (8), p.1734-1745

2019

Volltextzugriff (PDF)

BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening

American journal of cancer research, 2019-01, Vol.9 (11), p.2428-2441

2019

Volltextzugriff (PDF)

Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution

Journal of neuro-oncology, 2014-12, Vol.120 (3), p.597-605

2014

Volltextzugriff (PDF)

Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma

Journal of neuro-oncology, 2011-04, Vol.102 (2), p.273-280

2011

Volltextzugriff (PDF)

Abstract 235: Oncogene addiction switch from NOTCH to PI3K/AKT requires simultaneous targeting of NOTCH and PI3K pathway inhibition in glioblastoma

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.235-235

2013

Volltextzugriff (PDF)

NEW GLIOMA-ASSOCIATED AUTO-ANTIBODIES

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii41-iii41

2014

Volltextzugriff (PDF)

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas

Journal of neuro-oncology, 2017-03, Vol.132 (1), p.181-188

2017

Volltextzugriff (PDF)

PRESENCE OF A DISTINCTIVE MYELOID POPULATION IS ASSOCIATED WITH THE INVASIVE TUMOR PHENOTYPE OBSERVED AFTER ANTI-ANGIOGENESIS THERAPIES

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii15-iii15

2014

Volltextzugriff (PDF)

High-pitch Dual-source Computed Tomography Coupled with Sinogram-affirmed Iterative Reconstruction: Image Quality and Radiation Dose in Children

Hong Kong journal of radiology : HKJR = Xianggang fang she ke yi xue za zhi, 2018-03, p.40-47

2018

Volltextzugriff (PDF)

THE TREATMENT-RESISTANT MESENCHYMAL SIGNATURE IN GLIOBLASTOMA DERIVES FROM TUMOR CELLS INDEPENDENT OF STROMA

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii8-iii8

2014

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(214)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

Englisch
(227)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(211)
Life Sciences & Biomedicine
(183)
Humans
(119)
Biological And Medical Sciences
(81)
Male
(75)
Female
(71)
Medical Sciences
(69)
Animals
(55)
Middle Aged
(51)
Adult
(50)
Oncology
(47)
Aged
(42)
Pharmacology. Drug Treatments
(31)
Microbiology
(29)
Neurosciences & Neurology
(26)
Pharmacology & Pharmacy
(25)
Fundamental And Applied Biological Sciences. Psychology
(24)
Biochemistry & Molecular Biology
(23)
Infectious Diseases
(22)
Adolescent
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

Role of AKT signaling in DNA repair and clinical response to cancer therapy

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE

Current clinical development of PI3K pathway inhibitors in glioblastoma

Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells

Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center

Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02

Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma

Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway

Abstract CT238: Phase 2 study of dianhydrogalactitol (VAL-083) inpatients with MGMT-unmethylated, bevacizumab-naivepatients with MGMT-unmethylated, bevacizumab-naïve glioblastoma in the recurrent and adjuvant setting

Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients

Abstract 2798: Identification of gamma secretase inhibitor (GSI)-responsive GBM patients: Involvement of NOTCH, p53, and PI3K/MAPK signaling

Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs

BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening

Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution

Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma

Abstract 235: Oncogene addiction switch from NOTCH to PI3K/AKT requires simultaneous targeting of NOTCH and PI3K pathway inhibition in glioblastoma

NEW GLIOMA-ASSOCIATED AUTO-ANTIBODIES

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas

PRESENCE OF A DISTINCTIVE MYELOID POPULATION IS ASSOCIATED WITH THE INVASIVE TUMOR PHENOTYPE OBSERVED AFTER ANTI-ANGIOGENESIS THERAPIES

High-pitch Dual-source Computed Tomography Coupled with Sinogram-affirmed Iterative Reconstruction: Image Quality and Radiation Dose in Children

THE TREATMENT-RESISTANT MESENCHYMAL SIGNATURE IN GLIOBLASTOMA DERIVES FROM TUMOR CELLS INDEPENDENT OF STROMA

Suchergebnisse filtern